Chicago Elite
Founding partner of Goldman Ismail Tomaselli Brennan & Baum LLP, Tarek Ismail is a leading figure in pharma, medical device, and toxic tort litigation, routinely handling large-scale MDLs. Ismail serves as first-chair and lead trial counsel in major nationwide matters for clients, including Abbott, GSK, and Bayer, noted for his strategic judgment and effective courtroom advocacy.
Legal 500 Editorial commentary
Accolades
Chicago Elite
Mentions
Profile
Work Department
Litigation
Position
- Partner, Goldman Ismail Tomaselli Brennan & Baum LLP
Memberships
- Fellow, American College of Trial Lawyers, an invitation-only legal association made up of attorneys considered by judges and peers to be among the best trial lawyers
- Fellow, International Society of Barristers, an invitation-only society made up of the era’s best advocates committed to preserving the ideals of jury trials, the adversarial system, and an independent judiciary
- Fellow, Litigation Counsel of America’s Trial Lawyer Honorary Society, an invitation-only membership known for “its excellence in trial and appellate work, its integrity in practice, and its commitment to diversity throughout every aspect of the profession of law and the administration of justice”
Education
- University of Illinois College of Law (J.D., summa cum laude)
- Carleton College (B.A., Economics)
Content supplied by Goldman Ismail Tomaselli Brennan & Baum LLP
Key clients
- Merck & Co., Inc.; Merck Sharp & Dohme LLC; Schering-Plough Corp.; Schering Corp.; and MSP Singapore Co. LLC
- Bayer HealthCare Pharmaceuticals Inc.; Bayer HealthCare LLC; Bayer Corp.
Work highlights
Acts as lead trial counsel for Abbott Laboratories in litigation alleging that certain Abbott preterm nutritional products caused a serious gastrointestinal condition known as NEC, with trial approaching.